Modified immune cells attack rare cancers in new trial
Disease control
Ongoing
This study is testing a personalized cell therapy called Lete-Cel for people with advanced synovial sarcoma or myxoid/round cell liposarcoma. Doctors take a patient's own immune cells, modify them to target a specific protein found on these cancer cells, and infuse them back. The…
Phase: PHASE2 • Sponsor: USWM, LLC (dba US WorldMeds) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC